肝細(xì)胞癌肝切除術(shù)后大量腹水的危險因素分析
[Abstract]:The liver is the largest substance in the human body and plays a vital role in maintaining a number of physiological functions. If the liver is a disease, the health of the body will be greatly affected. In the face of a variety of liver diseases, hepatectomy is still a problem that doctors can take to solve the problem. The best way. Thanks to the problem of surgical pain, infection, hemostasis, and blood transfusion, modern surgery has developed greatly, and liver surgery has been developed for more than 100 years. The main target of hepatectomy is liver tumor (malignant tumor such as primary liver cancer, secondary liver cancer, and benign tumor such as the liver sea). Cavernous hemangioma, hepatic adenoma, hepatic lipoma, hepatofibroma, etc., which account for about 80% of the total proportion of the operation. Other diseases including intrahepatic bile duct stones, intrahepatic biliary bleeding, traumatic liver rupture, liver abscess, hepatic cyst, hepatic echinococcosis, etc. are also indications of hepatectomy, but in clinical work, surgeons are butting the liver. The patients undergoing surgical treatment are faced with many problems during the period of perioperative management. How to effectively evaluate the patient's liver reserve function and make a reasonable operation plan, and make the best efforts to reduce the incidence of complications after hepatectomy, improve the quality of life and shorten the time of hospitalization, so that the patients can get the most. In recent years, with the continuous development of surgical techniques, although some new materials and new technologies, such as radiofrequency ablation technology, have been developed and put into clinical application, the perioperative management of patients has been improved, the incidence and mortality of complications after hepatectomy have been significantly reduced by [1], The risk of hepatectomy is still not to be ignored. A large number of ascites, infection, bile leakage, poor healing of the incision, hepatic encephalopathy and other postoperative complications, resulting in a significant decline in the quality of life and prolonged hospitalization of the patients. These conditions will add to the economic pressure of the patients as soon as they appear, and they will also bring them to their families. A heavier psychological burden may even cause liver failure that threatens the life of the patient. In order to reduce the occurrence of this situation as much as possible, it is necessary to complete pre operation preparation and reasonable hand planning before surgery for hepatopathy, such as hepatocellular carcinoma, which need to be treated with surgical treatment. The effects of preoperative routine liver function parameters, liver disease background and operation conditions on a large number of ascites after hepatectomy, and the risk factors of massive ascites after hepatectomy for hepatectomy. Data and methods were collected from January 2015 to December 2015, due to hepatocyte carcinoma at the First Affiliated Hospital of Zhengzhou University, hepatobiliary and pancreatic surgery. The clinical data of 106 patients treated with hepatectomy were analyzed retrospectively. All patients were required to undergo complete preoperative examination and preparation. According to the results of CT, ultrasound and other imaging examinations, the size of the tumor, the location and the relationship with the peripheral vessels were clearly defined, and the surgical resection was reasonably selected. During the post hospital recovery, a large number of ascites were observed on the basis of the definition of 10m L/kg (kg) [2] before operation, and the data collected were classified into a large number of ascites and non large ascites. The demographic characteristics of the two groups (such as age, sex), and preoperative liver function parameters (such as blood, such as blood) Single factor and multiple factor Logistic analysis of the level of propane aminotransferase, serum prealbumin, serum total bilirubin, prothrombin activity, Child score, and liver disease background (such as viral hepatitis, cirrhosis, etc.) and operation (hepatectomy, hepatic portal blockage, intraoperative blood loss and blood transfusion) To determine the risk factors for a large number of ascites after hepatectomy for hepatocellular carcinoma. Results of the 106 patients enrolled in the study, a total of 26 patients had a large number of ascites after hepatectomy, the incidence of which was 24.5%. single factor analysis showed that a large number of ascites and non large ascites after hepatectomy were classified by Child and intraoperative blood transfusion, Preoperation portal hypertension, prothrombin time (PT), prothrombin activity (PTA), serum glutamic aminotransferase (AST) level, glutamyl transaminopeptidase (GGT) level, alkaline phosphatase (ALP) level, prealbumin (PA) level, cholinesterase (CHE) level, total bilirubin (TBIL) level, ICGR15, intraoperative hemorrhage and operation time between the 14 variables The difference had significant statistical significance (P0.05). The results of multifactor Logistic analysis showed that the 5 factors, prothrombin activity (PTA), serum alkaline phosphatase (ALP) level, prealbumin (PA) level, operation time and anterior portal hypertension were independent risk factors for massive ascites after hepatectomy for hepatocarcinoma. Conclusion 1. liver cell carcinoma liver After excision, a large number of ascites still have a high incidence (24.5%) before.2., prothrombin activity is low, prealbumin (PA) is low, serum alkaline phosphatase (ALP) is high. There is a lot of ascites in the patients with hepatocellular carcinoma with high pressure of anterior portal vein and long operation time, and a large amount of ascites.3. is more likely to be in the liver cell carcinoma after hepatectomy. A comprehensive and accurate assessment of liver function is necessary before the resection of the hepatectomy. Surgeons should take full consideration of the balance between the benefits and risks of surgical treatment when screening and formulating a clinical treatment for patients with hepatocellular carcinoma.
【學(xué)位授予單位】:鄭州大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2017
【分類號】:R735.7
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 戴光榮;劉文娜;李蓉;;肝功能評級指標(biāo)預(yù)測肝硬化患者食管靜脈曲張程度價值分析[J];實用肝臟病雜志;2013年03期
2 Kenji Miki;Yuichi Matsui;Masanori Teruya;Michio Kaminishi;Norihiro Kokudo;;Index of convexity:A novel liver function index using Tc-GSA scintigraphy[J];World Journal of Gastroenterology;2013年01期
3 許麗麗;謝峰;張紅娟;朱恒美;熊正香;楊甲梅;;皮硝外敷治療肝細(xì)胞癌肝切除術(shù)后腹水的臨床研究[J];中國醫(yī)藥指南;2012年35期
4 李靈敏;肖天利;陳文生;;MELD與CTP評分系統(tǒng)對TIPS術(shù)后患者預(yù)后的評價作用[J];第三軍醫(yī)大學(xué)學(xué)報;2009年08期
5 熊炬;張金輝;張朝霞;張瓊;邵英梅;趙晉明;溫浩;;原發(fā)性肝癌患者術(shù)前肝儲備功能的預(yù)測和術(shù)后評價[J];肝膽外科雜志;2007年02期
6 朱化剛;;術(shù)前肝臟儲備功能的判斷與安全肝切除量[J];肝膽外科雜志;2005年06期
7 ;Gene heterogeneity of hepatitis B virus isolates from patients with severe hepatitis B[J];Hepatobiliary & Pancreatic Diseases International;2005年04期
8 陳學(xué)穎,殷保兵;肝臟儲備功能的評估方法及意義[J];國外醫(yī)學(xué).外科學(xué)分冊;2005年02期
9 晏建軍,嚴(yán)以群;前白蛋白與肝功能損害及肝臟儲備功能的評價[J];肝膽外科雜志;2004年03期
10 周偉平,陳漢,吳孟超;術(shù)前評價肝臟儲備功能的方法與意義[J];肝膽外科雜志;2003年04期
,本文編號:2148593
本文鏈接:http://sikaile.net/yixuelunwen/zlx/2148593.html